Eli Lilly (NYSE: LLY) has been on a tear for the better part of the last decade, but the company has experienced a bit of a ...

Eli Lilly is partnering with Nvidia to build a supercomputer aimed at accelerating drug discovery. The collaboration aims to expedite medicine development cycles.

The Indianapolis-based drugmaker said the supercomputer will power an "AI factory" designed to accelerate drug discovery and development.

The idea was beautifully simple. One pill taken daily to melt away those excess pounds. The new breed of GLP-1 oral ...

Somehow, it’s becoming even harder to get a GLP-1.

Health-care companies fell as traders rotated out of the sector. The SPDR Select Sector Health Care exchange-traded fund, which tracks the health-care industry group of the S&P 500, fell 0.6%, paring ...

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

Eli Lilly partners with Nvidia to build the pharma industry’s most powerful AI supercomputer, aiming to speed up drug discovery and innovation.

Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer ...

Nvidia shares picked up strength in afternoon trading, rising 5.5% and pushing the AI chip giant's market value above $4.9 trillion for the first time, according to Dow Jones Market Data. Behind the ...

Eli Lilly and computing giant Nvidia are teaming up to build a new supercomputer that the pair say will be the most powerful owned and operated by a pharmaceutical company.